Kewaunee Scientific Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kewaunee Scientific.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	17.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kewaunee Scientific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqGM:KEQU - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
7/31/2024	202	18	8	11	N/A
4/30/2024	204	19	15	20	N/A
1/31/2024	201	9	12	18	N/A
10/31/2023	215	7	0	6	N/A
7/31/2023	219	4	-5	1	N/A
4/30/2023	219	1	-8	-4	N/A
1/31/2023	215	-1	-13	-10	N/A
10/31/2022	195	-3	-4	-2	N/A
7/31/2022	180	-6	-4	-2	N/A
4/30/2022	169	-6	-10	-8	N/A
1/31/2022	158	-9	-5	-3	N/A
10/31/2021	151	-7	-7	-5	N/A
7/31/2021	151	-4	0	2	N/A
4/30/2021	147	-4	-1	1	N/A
1/31/2021	143	-2	0	3	N/A
10/31/2020	144	-4	-4	-1	N/A
7/31/2020	145	-6	-1	1	N/A
4/30/2020	148	-5	2	4	N/A
1/31/2020	148	-5	-1	3	N/A
10/31/2019	146	-3	1	5	N/A
7/31/2019	144	1	0	5	N/A
4/30/2019	147	2	-2	2	N/A
1/31/2019	156	4	5	8	N/A
10/31/2018	162	5	4	8	N/A
7/31/2018	166	6	-4	0	N/A
4/30/2018	158	5	N/A	3	N/A
1/31/2018	148	5	N/A	5	N/A
10/31/2017	140	5	N/A	7	N/A
7/31/2017	135	4	N/A	12	N/A
4/30/2017	139	5	N/A	12	N/A
1/31/2017	138	4	N/A	10	N/A
10/31/2016	140	5	N/A	8	N/A
7/31/2016	135	4	N/A	6	N/A
4/30/2016	129	4	N/A	7	N/A
1/31/2016	125	3	N/A	-1	N/A
10/31/2015	120	3	N/A	-3	N/A
7/31/2015	119	3	N/A	4	N/A
4/30/2015	119	4	N/A	2	N/A
1/31/2015	116	4	N/A	7	N/A
10/31/2014	114	4	N/A	9	N/A
7/31/2014	110	4	N/A	6	N/A
4/30/2014	111	4	N/A	8	N/A
1/31/2014	116	4	N/A	6	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if KEQU's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if KEQU's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if KEQU's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if KEQU's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if KEQU's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if KEQU's Return on Equity is forecast to be high in 3 years time

Kewaunee Scientific Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific Corporation to Report Q1, 2025 Results on Sep 11, 2024

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific Corporation, Annual General Meeting, Aug 28, 2024

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Kewaunee Scientific Corporation to Report Q4, 2024 Results on Jun 26, 2024

Investor sentiment improves as stock rises 18%

Vice President of Human Resources recently sold US$107k worth of stock

Insider recently sold US$93k worth of stock

Insider notifies of intention to sell stock

Third quarter 2024 earnings released: EPS: US$0.87 (vs US$0.26 in 3Q 2023)

Kewaunee Scientific Corporation to Report Q3, 2024 Results on Mar 06, 2024

Investor sentiment improves as stock rises 18%

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

President recently sold US$137k worth of stock

President notifies of intention to sell stock

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.94 (vs US$0.086 loss in 2Q 2023)

Kewaunee Scientific Corporation to Report Q2, 2024 Results on Dec 06, 2023

First quarter 2024 earnings released: EPS: US$0.86 (vs US$0.27 loss in 1Q 2023)

Kewaunee Scientific Corporation, Annual General Meeting, Aug 23, 2023

New minor risk - Shareholder dilution

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

President exercised options and sold US$92k worth of stock

New minor risk - Insider selling

Insider recently bought US$657k worth of stock

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.47 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.086 loss per share (vs US$1.11 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: US$0.27 loss per share (vs US$0.48 loss in 1Q 2022)

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Kewaunee Scientific Corporation, Annual General Meeting, Aug 24, 2022

Full year 2022 earnings released: US$2.20 loss per share (vs US$1.33 loss in FY 2021)

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Insider recently bought US$421k worth of stock

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Kewaunee Scientific Corporation announced delayed 10-Q filing

First quarter 2022 earnings released: US$0.48 loss per share (vs US$0.22 loss in 1Q 2021)

Full year 2021 earnings released: US$1.33 loss per share (vs US$1.70 loss in FY 2020)

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Third quarter 2021 earnings released: EPS US$0.029 (vs US$0.70 loss in 3Q 2020)

Kewaunee Scientific Corporation to Report Q3, 2021 Results on Mar 10, 2021

New 90-day high: US$13.37

New 90-day high: US$12.56

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

New 90-day high: US$9.79

Second quarter 2021 earnings released: US$0.065 loss per share

Kewaunee Scientific reports Q2 results

New 90-day high: US$9.75

Kewaunee Scientific Corporation to Report Q2, 2021 Results on Dec 09, 2020

New 90-day low: US$8.33

New 90-day low: US$8.72

First quarter earnings released

Kewaunee Scientific Corporation to Report Q1, 2021 Results on Sep 08, 2020

New 90-day high - US$10.25

Kewaunee Scientific Corporation(NasdaqGM:KEQU) dropped from Russell Microcap Growth Index

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies